Current and emerging pharmacotherapeutic options for irritable bowel syndrome

JL Barboza, NJ Talley, B Moshiree - Drugs, 2014 - Springer
Abstract Treatment of irritable bowel syndrome (IBS) is challenging for both primary care
physicians and gastroenterologists because of the heterogeneity of the patient population …
被引用次数：26 相关文章

Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome.

J Barboza, N Talley, B Moshiree - Drugs, 2014 - search.ebscohost.com
Abstract Treatment of irritable bowel syndrome (IBS) is challenging for both primary care
physicians and gastroenterologists because of the heterogeneity of the patient population …

Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome

JL Barboza, NJ Talley, B Moshiree - Drugs, 2014 - infona.pl
Treatment of irritable bowel syndrome (IBS) is challenging for both primary care physicians
and gastroenterologists because of the heterogeneity of the patient population and the …

Current and emerging pharmacotherapeutic options for irritable bowel syndrome.

JL Barboza, NJ Talley, B Moshiree - Drugs, 2014 - europepmc.org
Treatment of irritable bowel syndrome (IBS) is challenging for both primary care physicians
and gastroenterologists because of the heterogeneity of the patient population and the …

Current and emerging pharmacotherapeutic options for irritable bowel syndrome

JL Barboza, NJ Talley, B Moshiree - Drugs (New York, NY), 2014 - scholarship.miami.edu
Treatment of irritable bowel syndrome (IBS) is challenging for both primary care physicians
and gastroenterologists because of the heterogeneity of the patient population and the …

Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome

JL Barboza, NJ Talley, B Moshiree - Drugs, 2014 - search.proquest.com
Abstract Treatment of irritable bowel syndrome (IBS) is challenging for both primary care
physicians and gastroenterologists because of the heterogeneity of the patient population …

[引用][C] Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome

JL BARBOZA, NJ TALLEY, B MOSHIREE - Drugs (Basel), 2014 - pascal-francis.inist.fr
Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Current and emerging pharmacotherapeutic options for irritable bowel syndrome

JL Barboza, NJ Talley, B Moshiree - Drugs, 2014 - pubmed.ncbi.nlm.nih.gov
Treatment of irritable bowel syndrome (IBS) is challenging for both primary care physicians
and gastroenterologists because of the heterogeneity of the patient population and the …

[引用][C] Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome

JL BARBOZA, NJ TALLEY, B MOSHIREE - Drugs, 2014 - Adis International